T 2455/18 (Controlled release formulations/ALPHAPHARM) of 18.05.2021
- European Case Law Identifier
- ECLI:EP:BA:2021:T245518.20210518
- Date of decision
- 18 May 2021
- Case number
- T 2455/18
- Online on
- 30 July 2021
- Petition for review of
- -
- Application number
- 07718791.2
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- CONTROLLED RELEASE FORMULATIONS COMPRISING UNCOATED DISCRETE UNIT(S) AND AN EXTENDED RELEASE MATRIX
- Applicant name
- Alphapharm Pty Ltd.
- Opponent name
- Agrobiogen GmbH Biotechnologie
Hamm&Wittkopp Patentanwälte PartmbB
Hoffmann Eitle - Board
- 3.3.07
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 123(2)European Patent Convention Art 54European Patent Convention Art 56European Patent Convention R 103(1)(a)European Patent Convention R 111(2)Rules of procedure of the Boards of Appeal Art 12(4)
- Keywords
- Main request(a) and Auxiliary requests 1(a)-4(a) - Novelty and amendments (No)
Auxiliary requests 5 and 5a - Novelty (No)
Auxiliary requests 6(a)-10(a) - Amendments (No)
Auxiliary requests 11(a)-17(a) - Inventive step (No) - Catchword
- see point 2.1.2 of the Reasons
- Cited cases
- -
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The patent is revoked.
3. The request of appellant-opponent 02 for reimbursement of the appeal fee is rejected.